Ascletis Pharma Inc.
OTC: ASCLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jinzi J. Wu
- Employees
- 202
- Headquarters
- Hangzhou, China
- IPO year
- 2019
- Market cap
- $1.4B
- Website
- https://www.ascential.com
Loading ASCLF…
Loading profile data…Frequently asked questions about ASCLF
What does Ascletis Pharma Inc. (ASCLF) do?
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and...
Where does ASCLF trade?
Ascletis Pharma Inc. (ASCLF) trades on the Other OTC.
What sector is ASCLF in?
Ascletis Pharma Inc. (ASCLF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ascletis Pharma Inc.?
Jinzi J. Wu is the chief executive officer of Ascletis Pharma Inc. (ASCLF).
Where is Ascletis Pharma Inc. headquartered?
Ascletis Pharma Inc. is headquartered in China.
Does ASCLF pay a dividend?
Ascletis Pharma Inc. (ASCLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ASCLF go public?
Ascletis Pharma Inc. (ASCLF) completed its initial public offering in 2019.